logo
How Robert F. Kennedy Jr. Is Already Reshaping Your Spice Rack

How Robert F. Kennedy Jr. Is Already Reshaping Your Spice Rack

Yahoo15-04-2025

Spice brand McCormick & Company announced in an earnings call that it is increasing efforts to reformulate products, as the United States Department of Health and Human Services targets food additives and dyes.
Several states have already banned a number of food dyes and additives, and the Food and Drug Administration has banned the use of Red Dye No. 3.
McCormick & Company may develop new products that align with health-focused food trends, like functional ingredients and high protein content.United States Secretary of Health and Human Services Robert F. Kennedy Jr.'s influence is already being felt throughout the food industry in the United States, and you may soon see its impact on your spice drawer.
In late March, McCormick & Company, one of the largest spice and seasoning brands in the world and a name that's likely in your own pantry, announced on an earnings call that it's working with its restaurant and food manufacturer clients to reformulate products, as customers move away from dyes and other food additives targeted by Kennedy and the Department of Health and Human Services (HHS).
"We are seeing a tick-up in reformulation activity," Brendan Folly, the chief executive officer of McCormick & Company, shared on the call. According to Foley, this is happening across its customer base. Per the executive, this aligns with "what you're seeing and being written out in the news media regarding what we're hearing from the new administration."
However, it's not just the HHS targeting food additives — individual states are taking action, too. In 2023, California passed a law banning four chemicals from food production: Red Dye No. 3, potassium bromate, brominated vegetable oil, and propylparaben.
All of these, with the exception of Red Dye No. 3 in a small number of candied and cocktail cherry products, are already banned from use in food across the European Union.
"We know they are harmful and that children are likely being exposed at a much higher rate than adults," Susan Little, senior advocate for California government affairs at the activist organization Environmental Working Group (EWG), shared at the time. "It makes no sense that the same products food manufacturers sell in California are sold in the EU but without these toxic chemicals. Our kids need to be protected, too."
Related: More Than 10,000 Chemical Food Additives Ended Up in the U.S. Food System — Here's Why
In March of this year, West Virginia passed a similar law, banning the use of Red Dye No. 3, Red Dye No. 40, Yellow Dye No. 5, Yellow Dye No. 6, Blue Dye No. 1, Blue Dye No. 2, and Green Dye No. 3, along with the preservatives butylated hydroxyanisole and propylparaben, from being used in drugs or food products sold in the state.
As Food & Wine previously reported, the dyes will be barred from use in "any meal served in a school nutrition program" starting on August 1, 2025. The dyes and preservatives will be banned statewide starting January 1, 2028.
"West Virginia ranks at the bottom of many public health metrics, which is why there's no better place to lead the Make America Healthy Again mission," Governor Patrick Morrisey shared in a statement about the law. "By eliminating harmful chemicals from our food, we're taking steps toward improving the health of our residents and protecting our children from significant long-term health and learning challenges."
New York state is working on similar legislation, the New York Food Safety and Disclosure Act, which would not only ban specific chemicals, but also require companies to disclose 'generally recognized as safe' (GRAS) additives on food packaging. Several other states have similar bills in the works, which consumers can track using the EWG's interactive legislation map.
While McCormick & Company is working on reformulating products, the brand notes that only a small number of its goods contain food dyes. Foley explains on the earnings call, "We don't really have a lot of usage of color in our products as you might expect, at least very, very few overall. Now with respect to [changes to] formulations, we are seeing more activity on that, definitely."
Related: States Are Cracking Down on Toxic Food Chemicals — Is Yours One of Them?
In January, the Food and Drug Administration officially banned Red Dye No. 3 over concerns about its connection to cancer, noting that it must be removed from food products by mid-January 2027 and from ingested drugs in 2028. McCormick announced in March that it will be phasing the dye out of its products before the ban goes into effect.
What can you expect from McCormick & Company moving forward? Foley hinted that the brand may soon launch new products to fit consumers' "healthier lifestyles" and align with growing trends like "hydration, functional foods, [and] high protein." Existing products are being reformulated, and consumers can expect new product releases to come.
Read the original article on Food & Wine

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US Health Secretary Kennedy guts vaccine advisory committee
US Health Secretary Kennedy guts vaccine advisory committee

Yahoo

time2 hours ago

  • Yahoo

US Health Secretary Kennedy guts vaccine advisory committee

By Ahmed Aboulenein, Michael Erman and Julie Steenhuysen WASHINGTON (Reuters) -Health Secretary Robert F. Kennedy Jr. has fired all 17 members of a U.S. Centers for Disease Control and Prevention panel of vaccine experts and is in the process of replacing them, his department said on Monday, drawing protest from many vaccine scientists. The move is the most far-reaching in a series of actions by Kennedy, a long-time vaccine skeptic, to reshape U.S. regulation of vaccines, food and medicine. Scientists and experts said the changes to the vaccine panel, which recommends how vaccines are used and by whom, would undermine public confidence in health agencies. Kennedy promised the move would raise public confidence. "Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," Kennedy said in a statement from the Department of Health and Human Services. Kennedy has for years sown doubt about the safety and efficacy of vaccines, but he pledged to maintain the country's existing vaccine standards to secure his appointment in President Donald Trump's administration. The Food and Drug Administration, which is overseen by Kennedy's department, has approved a number of vaccines during his tenure despite concerns over his stances. Even so, at least one senior Republican member of Congress expressed doubts about the changes in the panel. Kennedy said the Advisory Committee on Immunization Practices is rife with conflicts and has never turned down a vaccine, even though the decision to approve vaccines rests with the U.S. Food and Drug Administration. The CDC panel provides guidance to the CDC on which groups of people would most benefit from an already-approved vaccine. "That's a tragedy," said former FDA Chief Scientist Jesse Goodman. "This is a highly professional group of scientists and physicians and others... It's the kind of political meddling that will reduce confidence rather than increase confidence." The Pharmaceutical Research and Manufacturers of America called Kennedy's action concerning for public health. "Upending the ACIP membership increases uncertainty and vaccine skepticism, undermining the health gains achieved through vaccination," the industry body said in a statement late on Monday. Shares of vaccine makers Moderna and U.S.-listed shares of BioNTech fell more than 1%, while Pfizer was down marginally in extended trading on Monday. Kennedy said most panel members receive funding from drugmakers although members are required to declare any potential or perceived conflicts of interest that arise in the course of their tenure and any relevant business interests, positions of authority or other connections with organizations relevant to the committee's work. Kennedy and HHS provided no specific evidence of industry conflicts of interest among departing ACIP members. The CDC's web page for conflicts of interest, last updated in March, showed that one current member had recused herself from votes on a handful of vaccines because she had worked on clinical trials for their manufacturers. BIDEN APPOINTEES All 17 ACIP members were appointed under former President Joe Biden's administration, including 13 in 2024, HHS said. Without their removal, Trump's administration would not have been able to choose a majority of the committee until 2028. "This is not a political committee, it's never been partisan," said Dorit Reiss, a vaccine law expert at UC Law San Francisco. "It's an expert committee. Presidents have never been involved in ACIP membership." The decision drew criticism from Democrats in Congress, and one key Republican expressed concern. "Of course, now the fear is that the ACIP will be filled up with people who know nothing about vaccines except suspicion," said Republican U.S. Senator Bill Cassidy in a post on X. "I've just spoken with Secretary Kennedy, and I'll continue to talk with him to ensure this is not the case." Cassidy, a doctor from Louisiana who had expressed wariness about Kennedy's anti-vaccine views before clearing the path for him to become the nation's top health official, said at the time he had received assurances Kennedy would protect existing vaccination programs. The CDC panel will convene its next meeting June 25-27 at CDC headquarters in Atlanta, the department said. Vetting new panel members typically takes months, said one expert with close ties to the committee, who expressed doubts the newly appointed panel would be able to meet on time unless Kennedy and his team "have been working in the shadows" to onboard them months ahead of the announcement. Kennedy has drawn condemnation from health officials for his vaccine policies including what they say is a weak endorsement of the measles shots during an outbreak that has infected more than 1,000 mostly unvaccinated people and killed three. He announced last month the government was dropping its recommendation that healthy children and pregnant women should receive COVID shots, sidestepping the typical process. Traditionally, once the FDA approves vaccines for sale to the public, ACIP's role is to review data in a public meeting and vote on vaccine recommendations, which are then sent to the CDC director to sign off. The Affordable Care Act generally requires insurers to cover vaccines that are listed on the CDC vaccine schedules for adults and children. The recommendations also determine which vaccines the CDC's Vaccines for Children program will provide free of charge to those without insurance.

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program
RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program

Yahoo

time3 hours ago

  • Yahoo

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program

BENGALURU, India, June 09, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited ('RenaissThera'), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR). GIPR, an incretin receptor, is a validated target for peptide-based parenteral therapies where both stimulation and inhibition has shown efficacy in treating obesity and its co-morbidities. RenaissThera is developing novel, oral small molecules, both agonists and antagonists, as a more affordable and convenient alternative aiming to expand access for underserved populations in the global obesity market projected to reach USD 38 billion by 2032. Oral small molecules are more economical to manufacture and distribute than peptide-based obesity drugs. These molecules were designed and screened using proprietary AI and ML based platforms, followed by demonstrating in-vitro activity in cell lines and in-vivo activity to impact GIPR in mice to yield 'Hits'. RenaissThera now is advancing these Hits to the Lead optimization program to select candidates for pre-IND studies. RenaissThera is filing 'Composition of Matter' and utility patents for these oral novel small molecule GIPR modulators and continues to expand its innovation portfolio targeting GIP, GLP-1, and apelin receptors in obesity and diabetes. Its AI-powered Innovation Platform, integrating GenAI and machine learning tools, is accelerating the design and optimization of novel small molecules. 'We are grateful to our investors and collaborators for supporting us in reaching this milestone. Our team is focused on pushing candidates toward IND-readiness next year and we are in active discussions with potential pharma partners and investors interested in our obesity program,' said Meena, MD, CEO of RenaissThera. RenaissThera's progress was enabled through its collaboration with VedTechBio Research Private Limited which enabled access to its Agentic AI platform RxAgentAI and discovery expertise. 'We are very pleased with the outcomes of our collaboration with RenaissThera. This milestone further validates our platform and capabilities across key therapeutic areas including obesity, Type 2 diabetes, oncology, and inflammation,' said VedTechBio's Managing Director Sudhir Nagarajan. About RenaissThera RenaissThera is a Bengaluru-based biotech company developing affordable, AI-powered novel small-molecule therapies for high-unmet-need diseases like obesity and diabetes. Its goal is to innovate for underserved populations and expand global access to novel therapies. It leverages India's CRO ecosystem for early-stage R&D to deliver globally relevant innovation. For more information Please contact: Media: Lakshmi Ramakrishna lramakrishna@ Investor & Partnership: Ramkesh Meena bd@

RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members
RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members

Business Insider

time4 hours ago

  • Business Insider

RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members

In an opinion article published by The Wall Street Journal, Robert F. Kennedy Jr. stated: 'Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agencies, pharmaceutical companies or vaccines themselves, public confidence is waning… That is why, under my direction, the U.S. Department of Health and Human Services is putting the restoration of public trust above any pro- or antivaccine agenda… Today, we are taking a bold step in restoring public trust by totally reconstituting the Advisory Committee for Immunization Practices (ACIP). We are retiring the 17 current members of the committee, some of whom were last-minute appointees of the Biden administration. Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028… A clean sweep is needed to re-establish public confidence in vaccine science.' Confident Investing Starts Here:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store